Bill
Bill > HB1968
TN HB1968
TN HB1968AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.
summary
Introduced
01/22/2026
01/22/2026
In Committee
04/07/2026
04/07/2026
Crossed Over
Passed
05/18/2026
05/18/2026
Dead
Signed/Enacted/Adopted
05/18/2026
05/18/2026
Introduced Session
114th General Assembly
Bill Summary
As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.
AI Summary
This bill amends Tennessee law to add Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to a list of companies that the state's Attorney General may release from pending or future legal claims related to opioids, alongside Purdue Pharma L.P. This action is taken within the context of Tennessee Code Annotated (TCA) sections 20-13-203 and 33-11-103(p), which deal with legal proceedings and opioid-related matters. The bill also includes a severability clause, meaning that if any part of the act is found to be invalid, the rest of the act will still stand.
Committee Categories
Budget and Finance, Justice
Sponsors (1)
Last Action
Comp. became Pub. Ch. 888 (on 05/18/2026)
Bill Topics
Health
- ‐ Drug Abuse, Treatment, and Education
Law, Crime, and Family Issues
- ‐ Civil Law and Procedure
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://wapp.capitol.tn.gov/apps/Billinfo/default.aspx?BillNumber=HB1968&ga=114 | 01/22/2026 |
| BillText | https://publications.tnsosfiles.com/acts/114/pub/pc0888.pdf | 05/18/2026 |
| BillText | https://www.capitol.tn.gov/Bills/114/Bill/HB1968.pdf | 01/22/2026 |
| Fiscal Note - SB1495 | https://www.capitol.tn.gov/Bills/114/Fiscal/SB1495.pdf | 01/22/2026 |
Loading...